NCT00085111 2013-06-05
Bevacizumab in Treating Young Patients With Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
Clinical Trials
1 trialsUnspecified Childhood Solid Tumor, Protocol Specific × Bevacizumab × Other solid neoplasm × Clear all